Abstract PS5-01-04: Clinical predictors for first-line treatment duration in HER2-positive metastatic breast cancer Results from the AGMT_MBC-Registry
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: G. Rinnerthaler, S. P. Gampenrieder, A. Pichler, W. Herz, R. Pusch, C. Dormann, C. Suppan, M. Sandholzer, T. Winder, S. Heibl, L. Scagnetti, C. A. Schmitt, A. F. Zabernigg, D. Egle, C. Hager, P. Pichler, F. Roitner, J. Andel, K. Strasser-Weippl, R. Bartsch, V. Castagnaviz, M. Hubalek, M. Knauer, C. F. Singer, R. Greil
Institutions: Medical University of Graz, Paracelsus Medical University, LKH Hochsteiermark, Ordensklinikum Linz Barmherzige Schwestern, Krankenhaus der Elisabethinen, Landeskrankenhaus Feldkirch, Klinikum Wels-Grieskirchen, Johannes Kepler University of Linz, Kepler Universitätsklinikum, Innsbruck Medical University, Universität Innsbruck, Universitätsklinikum St. Pölten, Medical University of Vienna, Comprehensive Cancer Center Vienna, Arbeitsgemeinschaft medikamentöse Tumortherapie
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129251418
Cites:
Cited by:
Related to: